Chemed Corporation (NYSE:CHE) Receives Average Recommendation of “Hold” from Analysts

Shares of Chemed Corporation (NYSE:CHE) have earned a consensus recommendation of “Hold” from the six research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $498.00.

A number of research firms have issued reports on CHE. Oppenheimer lowered their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $422.00 price objective (down from $572.00) on shares of Chemed in a research report on Friday, February 27th. Zacks Research downgraded Chemed from a “hold” rating to a “strong sell” rating in a report on Wednesday, March 4th. Finally, Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the completion of the transaction, the chief executive officer owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. This trade represents a 2.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 3.29% of the company’s stock.

Hedge Funds Weigh In On Chemed

Several hedge funds have recently modified their holdings of CHE. Geneos Wealth Management Inc. raised its holdings in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares in the last quarter. Cetera Investment Advisers grew its stake in Chemed by 1.5% in the second quarter. Cetera Investment Advisers now owns 1,740 shares of the company’s stock valued at $847,000 after purchasing an additional 25 shares in the last quarter. Swiss National Bank increased its position in shares of Chemed by 1.1% during the 2nd quarter. Swiss National Bank now owns 27,900 shares of the company’s stock worth $13,585,000 after purchasing an additional 300 shares during the last quarter. Legal & General Group Plc raised its stake in shares of Chemed by 4.0% during the 2nd quarter. Legal & General Group Plc now owns 31,642 shares of the company’s stock worth $15,419,000 after purchasing an additional 1,206 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of Chemed by 9.9% during the 2nd quarter. Franklin Resources Inc. now owns 19,077 shares of the company’s stock worth $9,289,000 after purchasing an additional 1,713 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

CHE opened at $376.89 on Friday. The firm’s fifty day moving average is $425.13 and its two-hundred day moving average is $434.14. The firm has a market cap of $5.19 billion, a PE ratio of 20.52, a price-to-earnings-growth ratio of 1.48 and a beta of 0.46. Chemed has a twelve month low of $365.20 and a twelve month high of $623.60.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The business had revenue of $639.34 million for the quarter, compared to analyst estimates of $659.09 million. During the same period in the prior year, the business earned $6.83 EPS. The company’s revenue for the quarter was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Equities analysts forecast that Chemed will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s payout ratio is currently 13.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.